Statins are cholesterol-lowering drugs that some integrativein cancer care, a patient-centered approach combining the best of conventional care, self care, and evidence-informed complementary care in an integrated plan oncologists use off-label to improve survival, although statins can have serious side effects.

Affordability and access

Prescription required?

  • Yes. Oral statins are available with a prescription at pharmacies. The dose and formulation varies by the specific statin prescribed. Some, such as lovastatin, are available in extended-release formulation.

Other names or brands

Statins are also known as HMG-CoA reductase inhibitors. Generic and brand names available in the US:

  • Atorvastatin (Lipitor)
  • Pitavastatin (Livalo)
  • Fluvastatin (Lescol, Lescol XL)
  • Lovastatin (Mevacor, Altoprev)
  • Simvastatin (Zocor)
  • Pravastatin (Pravachol)
  • Rosuvastatin (Crestor)

Where to access

  • Drug stores and pharmacies
  • Online pharmacies

Affordability 

  • “Brand-name statin pricing ranges from $200–$500 for a month’s supply. Generic versions, which are equally effective, typically cost significantly less, ranging from $10–$50 per month.”1Parker C. Statins: How much do they cost, and how can you save? Optum Perks. October 29, 2023. Viewed June 11, 2024. Annual costs vary from US $120 to $6000. 
  • Insurance may cover costs; check with your insurance provider.

Commentary

Red yeast rice as a substitute for statins

Retired integrative oncologist and CancerChoices advisor Dwight McKee, MD: When I was in practice, I used red yeast rice › (RYR) that had adequate monokolin K content (which is identical to lovastatin). The pharmaceutical chemist who ‘invented’ lovastatin appears to have copied it from the yeast and knew of its long use in Chinese medicine for ‘excessive blood thickness.’ Several clinical studies in Asia have shown similar results in cancer control with RYR as with pharmaceutical statins. 

I’ve never seen any of the typical statin side effects from red yeast rice, and it’s been shown to have similar anticancer effects as statins in preclinical studiestesting a drug, a procedure, or another medical treatment in isolated cells or in animals; preclinical evidence is considered only an initial indication of possible effects in people. One problem however, is that in the US the FDA forbids RYR that contains monocolin K, since that’s a known ‘drug’ (lovastatin). In the European Union, the regulation is the opposite—manufacturers can’t make any health claims about red yeast rice UNLESS they have an adequate content of monocolin K [and very low levels of citrinin, which is a mycotoxin that can develop during production]. 

High levels of citrinin often accompany low levels of monocolin K. Citrinin is toxic to kidneys (nephrotoxic) in animals, but not yet tested in humans. I would advise against buying RYR in a drug store or health food store, as FDA does not regulate for citrinin content. ConsumerLab.com ›, a private company that analyzes and publishes their findings on many RYR products, found low levels of monocolin K, and substantial levels of the mycotoxin citirinin, in many over-the-counter brands of RYR.

Keep reading about statins

Authors

Nancy Hepp, MS

past Lead Researcher
View profile

Ms. Hepp is a researcher and communicator who has been writing and editing educational content on varied health topics for more than 20 years. She serves as lead researcher and writer for CancerChoices and also served as the first program manager. Her graduate work in research and cognitive psychology, her master’s degree in instructional design, and her certificate in web design have all guided her in writing and presenting information for a wide variety of audiences and uses. Nancy’s service as faculty development coordinator in the Department of Family Medicine at Wright State University also provided experience in medical research, plus insights into medical education and medical care from the professional’s perspective.

Nancy Hepp, MS past Lead Researcher

Laura Pole, MSN, RN, OCNS

Senior Clinical Consultant
View profile

Laura Pole is senior clinical consultant for CancerChoices. Laura is an oncology clinical nurse specialist who has been providing integrative oncology clinical care, navigation, consultation, and education services for over 40 years. She is the co-creator and co-coordinator of the Integrative Oncology Navigation Training at Smith Center for Healing and the Arts in Washington, DC. Laura also manages the “Media Watch Cancer News That You Can Use” listserv for Smith Center/Commonweal. In her role as a palliative care educator and consultant, Laura has served as statewide Respecting Choices Faculty for the Virginia POST (Physician Orders for Scope of Treatment) Collaborative as well as provided statewide professional education on palliative and end-of-life care for the Virginia Association for Hospices and Palliative Care.

For CancerChoices, Laura curates content and research, networks with clinical and organizational partners, brings awareness and education of integrative oncology at professional and patient conferences and programs, and translates research into information relevant to the patient experience as well as clinical practice.

Laura sees her work with CancerChoices as a perfect alignment of all her passions, knowledge and skills in integrative oncology care. She is honored to serve you.

Laura Pole, MSN, RN, OCNS Senior Clinical Consultant

Reviewers

Dr. Fuller-Shavel is a GMC-registered integrative medicine doctor with degrees in medicine and natural sciences from the University of Cambridge. Dr. Fuller-Shavel is a fellow of the College of Medicine and the vice chair for BSIO (British Society for Integrative Oncology). Alongside her science and medical training, Dr. Fuller-Shavel holds multiple qualifications in nutrition, integrative medicine, health coaching, herbal medicine, yoga, mindfulness and other mind-body approaches.

Dr. Fuller-Shavel is the director of Synthesis Clinic, an award-winning multidisciplinary integrative medicine practice in Hampshire, UK, specializing in women’s health, gut health (microbiome and gut-brain axis) and mental health. She combines her clinical work in women’s health and supporting patients with breast and gynecological cancer with education and training for healthcare professionals and research in precision cancer medicine and precision nutrition.

Nina Fuller-Shavel, MB, BChir, MA Hons, FBANT, IFMCP, DipIM, PG Cert RYT300

Last update: January 21, 2025

Last full literature review: April 2024

CancerChoices provides information about integrative in cancer care, a patient-centered approach combining the best of conventional care, self care and evidence-informed complementary care in an integrated plan cancer care. We review complementaryin cancer care, complementary care involves the use of therapies intended to enhance or add to standard conventional treatments; examples include supplements, mind-body approaches such as yoga or psychosocial therapy, and acupuncture therapies and self-care lifestyle actions and behaviors that may impact cancer outcomes; examples include eating health-promoting foods, limiting alcohol, increasing physical activity, and managing stress practices to help patients and professionals explore and integrate the best combination of conventionalthe cancer care offered by conventionally trained physicians and most hospitals; examples are chemotherapy, surgery, and radiotherapy and complementary therapies and practices for each person.

Our staff have no financial conflicts of interest to declare. We receive no funds from any manufacturers or retailers gaining financial profit by promoting or discouraging therapies mentioned on this site.

Learn more

References[+]